SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-072608
Filing Date
2023-08-31
Accepted
2023-08-31 08:30:25
Documents
12
Period of Report
2023-08-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184468-8k_abvc.htm   iXBRL 8-K 25512
  Complete submission text file 0001213900-23-072608.txt   197374

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20230831.xsd EX-101.SCH 3021
3 XBRL LABEL FILE abvc-20230831_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abvc-20230831_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT ea184468-8k_abvc_htm.xml XML 3218
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40700 | Film No.: 231227081
SIC: 2834 Pharmaceutical Preparations